• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

警惕 COVID-19 中的咽峡部核梭杆菌。

Beware of pharyngeal Fusobacterium nucleatum in COVID-19.

机构信息

State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.

Sichuan Center for Disease Control and Prevention, Chengdu, 610041, China.

出版信息

BMC Microbiol. 2021 Oct 11;21(1):277. doi: 10.1186/s12866-021-02336-6.

DOI:10.1186/s12866-021-02336-6
PMID:34635053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8504566/
Abstract

BACKGROUND

Fusobacterium nucleatum (F. n) is an important opportunistic pathogen causing oral and gastrointestinal disease. Faecalibacterium prausnitzii (F. p) is a next-generation probiotic and could serve as a biomarker of gut eubiosis/dysbiosis to some extent. Alterations in the human oral and gut microbiomes are associated with viral respiratory infection. The aim of this study was to characterise the oral and fecal bacterial biomarker (i.e., F. n and F. p) in COVID-19 patients by qPCR and investigate the pharyngeal microbiome of COVID-19 patients through metagenomic next-generation sequencing (mNGS).

RESULTS

Pharyngeal F. n was significantly increased in COVID-19 patients, and it was higher in male than female patients. Increased abundance of pharyngeal F. n was associated with a higher risk of a positive SARS-CoV-2 test (adjusted OR = 1.32, 95% CI = 1.06 ~ 1.65, P < 0.05). A classifier to distinguish COVID-19 patients from the healthy controls based on the pharyngeal F. n was constructed and achieved an area under the curve (AUC) of 0.843 (95% CI = 0.688 ~ 0.940, P < 0.001). However, the level of fecal F. n and fecal F. p remained unaltered between groups. Besides, mNGS showed that the pharyngeal swabs of COVID-19 patients were dominated by opportunistic pathogens.

CONCLUSIONS

Pharyngeal but not fecal F. n was significantly increased in COVID-19 patients, clinicians should pay careful attention to potential coinfection. Pharyngeal F. n may serve as a promising candidate indicator for COVID-19.

摘要

背景

具核梭杆菌(F. n)是一种重要的机会性病原体,可引起口腔和胃肠道疾病。普拉梭菌(F. p)是一种新一代益生菌,在某种程度上可以作为肠道菌群正常/失调的生物标志物。人类口腔和肠道微生物组的改变与病毒呼吸道感染有关。本研究旨在通过 qPCR 对 COVID-19 患者的口腔和粪便细菌生物标志物(即 F. n 和 F. p)进行特征分析,并通过宏基因组下一代测序(mNGS)研究 COVID-19 患者的咽微生物组。

结果

COVID-19 患者咽部分离的 F. n 显著增加,且男性患者高于女性患者。咽部分离的 F. n 丰度增加与 SARS-CoV-2 检测阳性的风险增加相关(调整后的 OR=1.32,95%CI=1.061.65,P<0.05)。基于咽 F. n 构建的区分 COVID-19 患者和健康对照者的分类器,曲线下面积(AUC)为 0.843(95%CI=0.6880.940,P<0.001)。然而,两组间粪便 F. n 和粪便 F. p 水平无变化。此外,mNGS 显示 COVID-19 患者咽拭子中以机会性病原体为主。

结论

COVID-19 患者咽部分离的 F. n 显著增加,而粪便 F. n 无明显变化,临床医生应密切注意潜在的合并感染。咽 F. n 可能成为 COVID-19 的一个有前景的候选指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/16a613322f30/12866_2021_2336_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/0658ef35a3d2/12866_2021_2336_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/6205dd55b991/12866_2021_2336_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/eabcd391480d/12866_2021_2336_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/286694f43297/12866_2021_2336_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/16a613322f30/12866_2021_2336_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/0658ef35a3d2/12866_2021_2336_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/6205dd55b991/12866_2021_2336_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/eabcd391480d/12866_2021_2336_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/286694f43297/12866_2021_2336_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6da/8507112/16a613322f30/12866_2021_2336_Fig5_HTML.jpg

相似文献

1
Beware of pharyngeal Fusobacterium nucleatum in COVID-19.警惕 COVID-19 中的咽峡部核梭杆菌。
BMC Microbiol. 2021 Oct 11;21(1):277. doi: 10.1186/s12866-021-02336-6.
2
Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.对确诊和疑似 COVID-19 患者的鼻咽拭子标本进行宏基因组下一代测序。
mBio. 2020 Nov 20;11(6):e01969-20. doi: 10.1128/mBio.01969-20.
3
Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.机会性检测具核梭杆菌作为早期肠道微生物失调的标志物。
BMC Microbiol. 2020 Jul 13;20(1):208. doi: 10.1186/s12866-020-01887-4.
4
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.COVID-19 患者住院期间肠道微生物组的变化。
Gastroenterology. 2020 Sep;159(3):944-955.e8. doi: 10.1053/j.gastro.2020.05.048. Epub 2020 May 20.
5
Differences in mortality in Fusobacterium necrophorum and Fusobacterium nucleatum infections detected by culture and 16S rRNA gene sequencing.通过培养和 16S rRNA 基因测序检测到坏死梭杆菌和核梭杆菌感染的死亡率差异。
Eur J Clin Microbiol Infect Dis. 2019 Jan;38(1):75-80. doi: 10.1007/s10096-018-3394-4. Epub 2018 Oct 29.
6
Coinfection of Fusobacterium nucleatum and Actinomyces israelii in mastoiditis diagnosed by next-generation DNA sequencing.通过下一代DNA测序诊断的乳突炎中具核梭杆菌和衣氏放线菌的混合感染
J Clin Microbiol. 2014 May;52(5):1789-92. doi: 10.1128/JCM.03133-13. Epub 2014 Feb 26.
7
Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.二甲双胍通过调节肠道微生物群发挥抗肿瘤作用,并挽救具核梭杆菌诱导的结直肠肿瘤发生。
EBioMedicine. 2020 Nov;61:103037. doi: 10.1016/j.ebiom.2020.103037. Epub 2020 Oct 9.
8
Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.具核梭杆菌肿瘤 DNA 水平与结直肠癌患者的生存相关。
Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1891-1899. doi: 10.1007/s10096-019-03649-1. Epub 2019 Jul 31.
9
Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to ?新冠病毒阳性患者鼻咽微生物组特征:我们能明确其作用吗?
Front Cell Infect Microbiol. 2021 Feb 15;11:625581. doi: 10.3389/fcimb.2021.625581. eCollection 2021.
10
A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of to Probiotics Populations, Based on Their Antagonistic Effect.一种基于益生菌拮抗作用的新型简单粪便生物标志物:/益生菌比值与结直肠癌。
Clin Chem. 2018 Sep;64(9):1327-1337. doi: 10.1373/clinchem.2018.289728. Epub 2018 Jun 18.

引用本文的文献

1
Oral microbiota and respiratory diseases: advances and perspectives.口腔微生物群与呼吸道疾病:进展与展望
Clin Microbiol Rev. 2025 Jun 12;38(2):e0015024. doi: 10.1128/cmr.00150-24. Epub 2025 Apr 2.
2
Bacterial Biomarkers of the Oropharyngeal and Oral Cavity during SARS-CoV-2 Infection.新型冠状病毒感染期间口咽和口腔的细菌生物标志物
Microorganisms. 2023 Nov 4;11(11):2703. doi: 10.3390/microorganisms11112703.
3
Periodontopathogens and and Their Roles in the Progression of Respiratory Diseases.牙周病原体及其在呼吸系统疾病进展中的作用。 需注意,原文中“and”重复使用,可能存在错误表述。

本文引用的文献

1
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案(第六版)
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
2
Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization.住院 COVID-19 患者中肠道和口腔微生物群的改变及其与 SARS-CoV-2 病毒载量的关系。
NPJ Biofilms Microbiomes. 2021 Jul 22;7(1):61. doi: 10.1038/s41522-021-00232-5.
3
Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19.
Pathogens. 2023 Aug 30;12(9):1110. doi: 10.3390/pathogens12091110.
4
Could Faecalibacterium prausnitzii Amount in the Gut Microbiota Be Used to Monitor the COVID-19 Severity?肠道微生物群中普拉梭菌的数量能否用于监测新冠病毒疾病的严重程度?
Turk J Gastroenterol. 2022 Oct;33(10):899-900. doi: 10.5152/tjg.2022.22100.
宏基因组分析揭示 COVID-19 患者口咽微生物群的改变。
Signal Transduct Target Ther. 2021 May 13;6(1):191. doi: 10.1038/s41392-021-00614-3.
4
Enriched Opportunistic Pathogens Revealed by Metagenomic Sequencing Hint Potential Linkages between Pharyngeal Microbiota and COVID-19.宏基因组测序揭示的丰富机会性病原体提示咽微生物群与 COVID-19 之间存在潜在关联。
Virol Sin. 2021 Oct;36(5):924-933. doi: 10.1007/s12250-021-00391-x. Epub 2021 May 12.
5
Alterations in the human oral and gut microbiomes and lipidomics in COVID-19.新冠病毒感染患者口腔和肠道微生物组及脂质组的变化。
Gut. 2021 Jul;70(7):1253-1265. doi: 10.1136/gutjnl-2020-323826. Epub 2021 Mar 31.
6
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing.基于 16S rDNA 测序的 COVID-19 患者鼻/咽微生物群落研究。
Int J Environ Res Public Health. 2021 Feb 23;18(4):2174. doi: 10.3390/ijerph18042174.
7
Detection of SARS-CoV-2 in fecal samples with different pretreatment methods and PCR kits.采用不同预处理方法和 PCR 试剂盒检测粪便样本中的 SARS-CoV-2。
BMC Microbiol. 2021 Feb 19;21(1):56. doi: 10.1186/s12866-021-02118-0.
8
Expression of the SARS-CoV-2 Receptor ACE2 and Proinflammatory Cytokines Induced by the Periodontopathic Bacterium in Human Respiratory Epithelial Cells.牙周病致病菌诱导人呼吸道上皮细胞表达 SARS-CoV-2 受体 ACE2 和促炎细胞因子。
Int J Mol Sci. 2021 Jan 29;22(3):1352. doi: 10.3390/ijms22031352.
9
Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity.主要肠道细菌种类变化与新型冠状病毒肺炎严重程度之间相关性的临床意义
Engineering (Beijing). 2020 Oct;6(10):1178-1184. doi: 10.1016/j.eng.2020.05.013. Epub 2020 Jun 8.
10
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.肠道微生物群落组成反映了 COVID-19 患者的疾病严重程度和功能失调的免疫反应。
Gut. 2021 Apr;70(4):698-706. doi: 10.1136/gutjnl-2020-323020. Epub 2021 Jan 11.